
WellMedRx Review
Best for: bundled GLP-1 with TRT or hair-loss care on one platform
WellMedRx is a multi-product compounded telehealth platform pairing GLP-1 weight-loss care with TRT, hair-loss, and sexual-health programs under one account. Clinical care runs through OpenLoop Health and other U.S.-licensed clinician networks, and it names its pharmacy partner, Mycelium Pharmacy. Base pricing isn't posted publicly beyond a 50%-off first-month promotion, with medication bundled into its care-coaching program.
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
WellMedRx is a solid telehealth option with balanced features and pricing.
WellMedRx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $0/mo
- FDA status
- No FDA warning letter on record
How we scored WellMedRx
Each dimension is scored algorithmically from WellMedRx’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.7/10At $0/mo, WellMedRx runs about 100% below the $170 median for GLP-1 providers.
Effectiveness25%
6.9/10WellMedRx offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.0/10Online intake and platform experience; 8 platform features disclosed.
Trust & Safety15%
5.5/10Some details we couldn't independently confirm; no FDA warning letters on file; dispenses through an accredited compounding pharmacy (last checked 2026-06-06).
Accessibility10%
4.9/10WellMedRx's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.3/10Coaching/nutrition support offered.
How we verified this WellMedRx review
Last checked 2026-06-06- Confirmed current pricing across 2 dose/plan tiers
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: low.
GLP-1 medications WellMedRx offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Ready to get started?
Plans and promotions change often — check WellMedRx's current pricing and active discounts before you decide.
What we like
- Named licensed pharmacy partner (Mycelium Pharmacy)
- Clinical care delivered through OpenLoop Health, an established clinician network
- Multi-product platform — one account covers weight loss, TRT, hair, and sexual health
- HIPAA-compliant badge on the home page
Watch-outs
- Monthly pricing not shown until after intake
- State coverage not disclosed — only 'a licensed professional in your state'
- No LegitScript registration visible on the home page
- No NABP .pharmacy seal
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
- Corporate address and named medical director not disclosed
WellMedRx: a one-account hub for weight loss, testosterone, hair, and sex-health
WellMedRx (the corporate entity is Wellmedr LLC) is built around a single idea: keep all of a man's — and it does skew toward men's-health programs — telehealth prescriptions under one login. Alongside compounded semaglutide and tirzepatide for weight loss, the same account covers a testosterone program (enclomiphene plus anastrozole), hair-loss treatment, and sexual-health/ED care. If you genuinely want two or three of those handled in one place, that bundling is the real reason to look here. If you only want GLP-1 weight loss, the multi-vertical angle buys you nothing, and there are more transparent single-purpose providers.
The pricing is the catch — there isn't a number to show you
This is the honest sticking point. WellMedRx does not publish a base monthly price anywhere on its public site. The only figure it advertises is '50% off your first month,' which is a discount on a number you can't see until you finish intake. Its pricing page and About page both return 404 errors at the time of our review. So we can't tell you what you'll actually pay, and neither can the site before you hand over your information.
For context, the typical compounded GLP-1 program in our database runs around $170 a month ongoing. WellMedRx bundles medication into a care-coaching program rather than itemizing the drug, which can be fine — but it also makes it harder to compare apples to apples. Treat any quote you get after intake as the real price, and don't assume the 50%-off teaser reflects what month two and beyond will cost.
What 'no hidden fees' should mean for you
WellMedRx markets 'affordable pricing with no hidden fees' and 'unlimited provider messaging.' Those are good things if they hold up. But because the base rate isn't posted, the burden is on you to confirm the recurring monthly cost, what the medication itself costs once the promo lapses, and whether anything (labs, shipping, consult) sits outside the headline number before you commit.
The medications and who actually fills them
On the weight-loss side you'll find compounded tirzepatide (marketed as a GLP-1/GIP option) and a microdose semaglutide product the site brands 'Energy & Focus+,' which pairs semaglutide with NAD+ and B12. Both are compounded formulations, not FDA-approved finished drugs — an important distinction. Compounded versions are made by a pharmacy to order and don't carry the same FDA review or manufacturer quality guarantees as Wegovy, Zepbound, Ozempic, or Mounjaro. That's a trade-off thousands of patients accept for access and cost, but you should make it knowingly.
To its credit, WellMedRx names names where many compounded sellers stay vague. It identifies its pharmacy partner outright as Mycelium Pharmacy, and it says clinical care is delivered through OpenLoop Health and other networks of U.S.-licensed clinicians. OpenLoop is an established telehealth clinician network used by a number of platforms, so the medical layer isn't a black box — that's a meaningful point in its favor.
What sets it apart — and what it's missing
- Genuine differentiator: true multi-product care (weight loss + TRT + hair + sexual health) on one account, with a named pharmacy (Mycelium) and a named clinician network (OpenLoop).
- HIPAA-compliant badge displayed on the home page.
- Unlimited provider messaging included in the program.
- Missing: no LegitScript certification visible, no NABP .pharmacy seal, no published corporate address, and no named medical director.
- Missing: the list of states it actually serves — the site only promises 'a licensed professional in your state' without telling you which states qualify.
Who should choose WellMedRx — and who should skip it
Consider it if you specifically want to consolidate GLP-1 weight loss with a men's-health program like TRT or hair loss, and you're comfortable getting a firm price only after intake. The named pharmacy and OpenLoop clinical network make it more legible than a lot of anonymous compounding sites.
Skip it if price transparency matters to you up front, if you want only weight-loss care, or if third-party safety credentials (LegitScript, NABP) are a must-have. A provider that won't show its base price, its state list, or its medical director before you sign up is asking for a fair amount of trust without offering much in return.
Trust and safety: a low-confidence read
There are no FDA warning letters on file for WellMedRx, which is a plus. But the absence of a posted price, a disclosed corporate address, a named medical director, an explicit state list, and any LegitScript or NABP credential leaves real gaps. We rate our confidence in this listing as low — not because we found anything alarming, but because the company discloses so little publicly that a careful shopper can't fully vet it before handing over personal and payment information. See our scoring methodology for how we weigh transparency and credentials.
The bottom line
WellMedRx is a credible-looking, multi-product telehealth platform with a named pharmacy and a recognized clinician network behind it — strengths that lift it above the most opaque compounders. The dealbreaker for many will be that it won't tell you what you'll pay, which states it covers, or who runs it medically until you're already in the funnel. If the bundled men's-health angle is the draw, go in with eyes open: finish intake, get the real recurring price in writing, confirm your state, and only then decide.
If you're weighing alternatives, Telos Rx ($49/month) and bmiMD ($99/month) are among the closest options we track to WellMedRx.
Ready to start with WellMedRx?
Starting at $0/month. See current pricing and start your free consultation.
Alternatives to WellMedRx
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this WellMedRx review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with WellMedRx?
Starting at $0/month. See current pricing and start your free consultation.